TANDEM DIABETES CARE, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.47 USD | -0.60% |
|
+3.52% | +22.90% |
| 04-30 | North American Morning Briefing : More Earnings -2- | DJ |
| 04-29 | Wells Fargo Upgrades Tandem Diabetes Care to Overweight From Equalweight, Price Target is $45 | MT |
Chart calendar Tandem Diabetes Care, Inc.
9.QOUhhirPww6txqxUoA23EN7ssJaD9XNdQYUkioxqRRU.E5IS5GeI9jyctMEf6kzyIZi_4OPivwNuee9cwbQbMiADr2rQHJCQdJ7x9Q~4a38c3f402e90cf717af317218790027
Upcoming events on Tandem Diabetes Care, Inc.
Past events on Tandem Diabetes Care, Inc.
| 13/03/2024 19:35 | Barclays Global Healthcare Conference |
| 12/03/2024 17:20 | Oppenheimer Healthcare MedTech & Services Conference |
| 06/03/2024 16:00 | Raymond James Institutional Investors Conference |
| 04/03/2024 18:30 | TD Cowen Health Care Conference |
| 29/02/2024 18:00 | Citi Unplugged Medtech and Life Sciences Access Day |
| 21/02/2024 21:30 | Q4 2023 Earnings Call |
| 21/02/2024 21:05 | Q4 2023 Earnings Release |
| 29/11/2023 15:30 | Piper Sandler Healthcare Conference |
| 15/11/2023 15:15 | Wolfe Research Healthcare Conference |
| 14/11/2023 08:30 | Jefferies London Healthcare Conference |
| 01/11/2023 20:30 | Q3 2023 Earnings Call |
| 01/11/2023 20:02 | Q3 2023 Earnings Release |
| 13/09/2023 16:25 | Baird Global Healthcare Conference |
| 11/09/2023 18:35 | Morgan Stanley Global Healthcare Conference |
| 07/09/2023 20:45 | Wells Fargo Healthcare Conference |
| 16/08/2023 19:00 | UBS Genomics 2.0 and MedTech Innovations Summit |
| 03/08/2023 21:30 | Q2 2023 Earnings Call |
| 03/08/2023 21:05 | Q2 2023 Earnings Release |
| 08/06/2023 18:30 | Jefferies Global Healthcare Conference |
| 24/05/2023 23:00 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 362 363 -0.24% | 499 472 5.66% | 703 692 1.59% | 801 803 -0.22% | 748 763 -1.96% | 845 |
|
EBITDA Million USD | Released Forecast Spread | -10,7 -12,7 16.04% | 2,49 -5,20 148% | 36,5 40,8 -10.6% | 53,4 51,6 3.58% | -9,19 9,38 -197.94% | 1,74 |
|
EBIT Million USD | Released Forecast Spread | -16,7 -21,0 20.27% | -7,96 -14,3 44.43% | 22,7 26,5 -14.55% | -45,8 -51,6 11.13% | -113 -135 16.75% | -119 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,6 -29,4 16.19% | -36,3 -44,9 19.17% | 15,9 20,9 -23.91% | -92,9 -73,7 -26.06% | -220 -208 -5.86% | -112 |
|
Net income Million USD | Released Forecast Spread | -24,8 -29,4 15.87% | -34,4 -43,3 20.53% | 15,6 20,6 -24.35% | -94,6 -84,6 -11.83% | -223 -210 -5.87% | -109 |
|
EPS USD | Released Forecast Spread | -0,42 -0,50 16.11% | -0,56 -0,72 21.75% | 0,24 0,32 -24.63% | -1,47 -1,31 -12.5% | -3,43 -3,24 -6.03% | -1,66 |
| Announcement Date | 24/02/20 | 24/02/21 | 22/02/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 210 199 5.62% | 176 168 4.57% | 200 205 -2.37% | 205 207 -1.03% | 221 222 -0.67% | 169 170 -0.56% | 196 197 -0.54% | 186 193 -3.74% | 197 203 -2.98% | 174 | 205 | 218 | 249 | 200 |
|
EBITDA Million USD | Released Forecast Spread | 16,3 20,4 -20.35% | 6,40 16,0 -59.88% | 11,4 26,5 -56.78% | 9,87 23,1 -57.27% | 25,7 25,0 2.83% | -20,2 -10,3 -96.71% | 5,27 -8,49 162% | 1,46 3,52 -58.61% | 4,25 12,9 -67.02% | -24,6 | -5,73 | 10,3 | 21,5 | -14,6 |
|
EBIT Million USD | Released Forecast Spread | 12,7 16,4 -22.54% | -15,3 -4,82 -217.9% | -12,2 0,53 -2421.16% | -15,9 -2,36 -572.24% | -2,39 -3,13 23.75% | -128 -36,5 -250.53% | -38,8 -34,8 -11.41% | -23,3 -27,4 14.94% | -22,5 -17,7 -27.28% | -52,9 | -35,2 | -21,1 | -9,95 | -40,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 11,1 14,6 -23.83% | -16,4 -9,13 -80.03% | -13,0 1,18 -1200.49% | -47,3 -3,73 -1169.6% | -16,1 -2,74 -488.17% | -124 -33,1 -273.62% | -34,6 -33,0 -4.95% | -30,7 -23,3 -31.97% | -31,3 -18,1 -73.05% | -52,4 | -32,9 | -20,4 | -9,59 | -42,3 |
|
Net income Million USD | Released Forecast Spread | 10,8 14,3 -24.27% | -14,7 -5,81 -153.06% | -15,1 0,74 -2147.15% | -49,0 -3,07 -1493.26% | -15,9 -3,11 -410.1% | -124 -32,3 -283.75% | -35,8 -32,6 -9.66% | -33,0 -32,9 -0.33% | -30,0 -17,4 -72.68% | -50,3 | -33,1 | -19,5 | -7,89 | -32,0 |
|
EPS USD | Released Forecast Spread | 0,16 0,22 -27.75% | -0,23 -0,09 -155.56% | -0,23 0,01 -1982.16% | -0,76 -0,05 -1517.02% | -0,25 -0,05 -400% | -1,92 -0,50 -282.49% | -0,55 -0,51 -7.61% | -0,51 -0,51 -0.97% | -0,46 -0,27 -73.14% | -0,77 | -0,51 | -0,30 | -0,12 | -0,49 |
| Announcement Date | 22/02/22 | 04/05/22 | 03/08/22 | 02/11/22 | 22/02/23 | 03/05/23 | 03/08/23 | 01/11/23 | 21/02/24 | - | - | - | - | - |
| Today 21:01 | ATRICURE, INC.: Q1 2024 Earnings Release |
| Today 21:10 | ENVISTA HOLDINGS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | TANDEM DIABETES CARE, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | DENTSPLY SIRONA INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | TELEFLEX INCORPORATED: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | ZIMMER BIOMET HOLDINGS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | BECTON, DICKINSON AND COMPANY: Q2 2024 Earnings Release |
| 02/05/2024 12:00 | AVANOS MEDICAL, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:15 | BAXTER INTERNATIONAL INC.: Q1 2024 Earnings Release |
| 05/05/2024 | TAIDOC TECHNOLOGY CORPORATION: Q1 2024 Earnings Release (Projected) |
Past sector events for Tandem Diabetes Care, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TNDM Stock
- Calendar Tandem Diabetes Care, Inc.
